NPM1 and acute myeloid leukemia: This study aimed to investigate the presence, frequency, and predictive value of morphologically identified CLBs at diagnosis in a subsequent series of NPM1-mutated patients with AML defined after a fully integrated diagnostic approach, including the real-time identification of NPM1 mutations and normal karyotypes.